GB1589982A - Organic compounds - Google Patents

Organic compounds Download PDF

Info

Publication number
GB1589982A
GB1589982A GB30856/77A GB3085677A GB1589982A GB 1589982 A GB1589982 A GB 1589982A GB 30856/77 A GB30856/77 A GB 30856/77A GB 3085677 A GB3085677 A GB 3085677A GB 1589982 A GB1589982 A GB 1589982A
Authority
GB
United Kingdom
Prior art keywords
composition according
surfactant
active agent
film
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB30856/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB1589982A publication Critical patent/GB1589982A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB30856/77A 1976-07-27 1977-07-22 Organic compounds Expired GB1589982A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH958876 1976-07-27

Publications (1)

Publication Number Publication Date
GB1589982A true GB1589982A (en) 1981-05-20

Family

ID=4353539

Family Applications (1)

Application Number Title Priority Date Filing Date
GB30856/77A Expired GB1589982A (en) 1976-07-27 1977-07-22 Organic compounds

Country Status (27)

Country Link
JP (1) JPS5315411A (fi)
AR (1) AR216479A1 (fi)
AT (1) AT369987B (fi)
AU (1) AU515738B2 (fi)
BE (1) BE857122A (fi)
CA (1) CA1095833A (fi)
CY (1) CY1261A (fi)
DE (1) DE2732335C2 (fi)
DK (1) DK325677A (fi)
ES (1) ES461020A1 (fi)
FI (1) FI772217A (fi)
FR (1) FR2359607A1 (fi)
GB (1) GB1589982A (fi)
GR (1) GR65014B (fi)
HK (1) HK81884A (fi)
HU (1) HU178340B (fi)
IE (1) IE45534B1 (fi)
IL (1) IL52587A (fi)
KE (1) KE3441A (fi)
MY (1) MY8400057A (fi)
NL (1) NL176227C (fi)
NO (1) NO149874C (fi)
NZ (1) NZ184722A (fi)
PT (1) PT66850B (fi)
SE (1) SE437469B (fi)
SG (1) SG53884G (fi)
ZA (1) ZA774536B (fi)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892738A (en) * 1980-05-21 1990-01-09 Shionogi & Co., Ltd. Sustained-release granular pharmaceutical preparations
US7105180B2 (en) 1999-12-09 2006-09-12 Ratiopharm Gmbh Stable galenic preparations comprising a benzimidazole and method for the production thereof

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS5748908A (en) * 1980-09-08 1982-03-20 Kyorin Pharmaceut Co Ltd Prolonged release type nicomol pharmaceutical
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS61254522A (ja) * 1985-05-02 1986-11-12 Takada Seiyaku Kk 錠剤組成物
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
GB1301849A (fi) * 1969-12-15 1973-01-04
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892738A (en) * 1980-05-21 1990-01-09 Shionogi & Co., Ltd. Sustained-release granular pharmaceutical preparations
US7105180B2 (en) 1999-12-09 2006-09-12 Ratiopharm Gmbh Stable galenic preparations comprising a benzimidazole and method for the production thereof

Also Published As

Publication number Publication date
HU178340B (en) 1982-04-28
IE45534L (en) 1978-01-27
IL52587A0 (en) 1977-10-31
DE2732335C2 (de) 1983-01-20
NZ184722A (en) 1980-10-24
NL7708162A (nl) 1978-01-31
DK325677A (da) 1978-01-28
NL176227B (nl) 1984-10-16
DK325877A (da) 1978-01-20
MY8400057A (en) 1984-12-31
PT66850B (fr) 1979-03-13
NO772575L (no) 1978-01-30
SE7708265L (sv) 1978-01-28
NO149874B (no) 1984-04-02
GR65014B (en) 1980-06-13
HK81884A (en) 1984-11-25
ZA774536B (en) 1979-02-28
NL176227C (nl) 1985-03-18
JPS5315411A (en) 1978-02-13
PT66850A (fr) 1977-08-01
SE437469B (sv) 1985-03-04
IE45534B1 (en) 1982-09-22
JPS5726650B2 (fi) 1982-06-05
FR2359607A1 (fr) 1978-02-24
AR216479A1 (es) 1979-12-28
DE2732335A1 (de) 1978-02-02
ATA541377A (de) 1982-07-15
BE857122A (fr) 1978-01-25
SG53884G (en) 1985-03-08
IL52587A (en) 1980-09-16
FR2359607B1 (fi) 1980-02-22
CY1261A (en) 1984-11-23
KE3441A (en) 1984-09-14
CA1095833A (en) 1981-02-17
NO149874C (no) 1984-07-11
ES461020A1 (es) 1979-05-01
FI772217A (fi) 1978-01-28
AU515738B2 (en) 1981-04-30
AT369987B (de) 1983-02-25
AU2730177A (en) 1979-02-01

Similar Documents

Publication Publication Date Title
RU2193880C2 (ru) Покрытая пленкой таблетка улучшенной безопасности для верхних отделов желудочно-кишечного тракта
US4309404A (en) Sustained release pharmaceutical compositions
US4309405A (en) Sustained release pharmaceutical compositions
KR890004688B1 (ko) 서방형 약제의 담체 조성물
US6190692B1 (en) Time-specific controlled release capsule formulations and method of preparing same
KR940000100B1 (ko) 메토프롤롤염을 함유하는 서방형 제제의 제조방법
EP0632720B1 (en) Hydroxyethylcellulose-based sustained-release oral drug dosage froms
JP2776856B2 (ja) 薬剤持続放出マトリツクス及び方法
US4309406A (en) Sustained release pharmaceutical compositions
US4904476A (en) Formulations providing three distinct releases
US4291016A (en) Enteric coated mixture of 4-(2-hydroxy-3-isopropylamino-propoxy) indole and sodium lauryl sulphate
GB2055577A (en) Substained release pharmaceutical compositions
JPH07501073A (ja) リゼドロネート遅延放出組成物
EP0221732A2 (en) Sustained release tablets
GB1589982A (en) Organic compounds
JPH07258085A (ja) アルフゾシン塩酸塩を含む徐放性製剤
PL192648B1 (pl) Preparat farmaceutyczny o kontrolowanym uwalnianiu, zawierający inhibitor ACE jako substancję aktywną
EP0094123A2 (en) Therapeutic granules
CN115813920B (zh) 1,2,4三唑并4,3-b哒嗪衍生物在制备治疗慢性肾病的药物中的应用
WO2002067905A1 (en) A sustained release pharmaceutical formulation
JPH0656677A (ja) 制酸剤組成物
NZ207768A (en) Sustained release tablets comprising dipyridamole
DE2802114A1 (de) Neue pharmazeutische zusammensetzung und verfahren zu deren herstellung
EP2682109B1 (en) Combined immediate release formulations of flurbiprofen and famotidine
KR830001644B1 (ko) 서방출형 제제의 제조 방법

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee